(Q33401083)

26 July 2017

title

Evaluation of bleeding-related episodes in patients with immune thrombocytopenia (ITP) receiving romiplostim or medical standard of care (English)

1 reference

Aristoteles A N Giagounidis

26 July 2017

1 reference

1 reference

5

object named as

Aristoteles Giagounidis

1 reference

26 July 2017

Roberto Stasi

1

1 reference

26 July 2017

Magaral Murali

2

1 reference

26 July 2017

Marc Michel

3

1 reference

26 July 2017

Jean-François Viallard

4

1 reference

26 July 2017

Ann Janssens

6

1 reference

26 July 2017

Jason Legg

7

1 reference

26 July 2017

Robert Deuson

8

1 reference

26 July 2017

Mark D Danese

9

1 reference

26 July 2017

publication date

5 May 2012

1 reference

International Journal of Hematology

26 July 2017

published in

1 reference

26 July 2017

volume

96

1 reference

26 July 2017

issue

1

1 reference

26 July 2017

page(s)

26-33

1 reference

The ITP syndrome: pathogenic and clinical diversity

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1088-8

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1088-8

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1088-8

Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1088-8

Romiplostim or standard of care in patients with immune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1088-8

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1088-8

International consensus report on the investigation and management of primary immune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1088-8

Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1088-8

Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1088-8

Characteristics and outcome of immune thrombocytopenia in elderly: results from a single center case-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1088-8

Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22562409

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22562409

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12185-012-1088-8

1 reference

Dimensions Publication ID

26 July 2017

1002721519

0 references

1 reference